IP Library Granted Patent US 11,458,097
Granted Patent B2
US 11,458,097 · App. 16/089,833 · Granted Oct 4, 2022

Biological agent-exosome compositions and uses thereof

Inventors: Elena V. Batrakova (Durham, NC); Alexander V. Kabanov (Chapel Hill, NC); Marina Sokolsky (Chapel Hill, NC); Matthew J. Haney (Chapel Hill, NC); Dongfen Yuan (Chapel Hill, NC); Myung Soo Kim (Chapel Hill, NC)
Assignee: The University of North Carolina at Chapel Hill
A61K9/127A61K31/337A61K31/7088A61K45/06A61K47/65A61P35/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,458,097
App. No.
16/089,833
Granted
Oct 4, 2022
Kind
B2
Abstract

The present invention relates to compositions comprising exosomes and biological agents and methods of using the compositions for the delivery of biological agents to cells and to subjects.

Claims (14)

1. A composition for delivery of a biological agent to a cell, the composition comprising an exosome comprising the biological agent, wherein the biological agent is not naturally present in the exosome and is a neurotrophin, wherein the exosome is isolated from a macrophage/monocyte.

2. The composition of claim 1 , wherein the exosome further comprises a targeting agent.

3. The composition of claim 2 , wherein the targeting agent is attached to the surface of the exosome.

4. The composition of claim 3 , wherein the targeting agent is attached using a polymeric linker.

5. The composition of claim 4 , wherein the polymer linker is a water soluble polymer liker.

6. The composition of claim 2 , wherein the targeting agent or polymeric linker is connected to a lipid group in or on the exosome.

7. The composition of claim 1 , wherein the exosome is modified with a molecule containing multiple charges.

8. The composition of claim 7 , wherein the molecule containing multiple charges is a polyion or a lipid.

9. The composition of claim 1 , further comprising a pharmaceutically acceptable carrier.

10. A method of delivering a biological agent to a cell, comprising contacting the cell with the composition of claim 1 , thereby delivering the biological agent to the cell.

11. A method of enhancing delivery of a biological agent to a cell in a tumor microenvironment, to a cancer cell, or to a central nervous system cell, comprising contacting the cell with the composition of claim 1 , thereby enhancing delivery of the biological agent to the cell relative to the delivery of the biological agent in the absence of an exosome.

12. A method of delivering a biological agent to a subject, across the blood brain barrier of a subject, or to inflamed tissue of a subject, comprising delivering the composition of claim 1 to the subject, thereby delivering the biological agent to the subject.

13. A method of treating a disorder in a subject in need thereof, comprising delivering a therapeutically effective amount of the composition of claim 1 to the subject, wherein the biological agent is effective for treating the disorder, thereby treating the disorder in the subject.

14. The composition of claim 1 , wherein the neurotrophin is brain derived neurotrophic factor, nerve growth factor, neurotrophin 3, neurotrophin 4, glial cell derived neurotrophic factor, artemin, neurturin, persephin, or ciliary neurotrophic factor.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 15, 2019
From: BATRAKOVA, ELENA V.; KABANOV, ALEXANDER V.; SOKOLSKY, MARINA; HANEY, MATTHEW J.; YUAN, DONGFEN; KIM, MYUNG SOO
To: THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
Reel/Frame 048015/0496 →
Continuity (2)
Provisional Application 62315389 · Mar 30, 2016
Related Publication 20200297631A1 · Sep 24, 2020